Excellence in Healthcare
Both medications have shown promising results in weight loss. Both tirzepatide and semaglutide are injectable medications used to treat type 2 diabetes and promote weight loss, but they differ in their mechanisms of action and, consequently, their efficacy and side effect profiles. Tirzepatide, a dual GIP/GLP-1 receptor agonist, and semaglutide, a GLP-1 receptor agonist.
Tirzepatide and semaglutide offer significant benefits for people with type 2 diabetes and those seeking effective weight management.
Although they belong to the same drug class, tirzepatide and semaglutide differ in their dosing schedules. Both medications are administered once a week as a subcutaneous injection, just under the skin in the abdomen, thigh, or upper arm. Follow your doctor's instructions for proper administration.